Creative Medical Technology buys 4 million Biodefense shares for $200,000 cash and 1 million shares on Sept. 24
CELZ•Creative Medical Technology bought 4 million Biodefense shares on Sept. 24 for $200,000 cash and 1 million of its own shares, and holds 80% of Biodefense after the deal.
1. Biodefense stake
Creative Medical Technology Holdings bought 4 million Biodefense shares on Sept. 24, paying $200,000 in cash and issuing 1 million shares. The company holds 80% of Biodefense after the deal.
